Xencor Inc (XNCR)
Healthcare
Biotechnology
19.40 $
-4.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Xencor Inc (XNCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -135 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 | 27 | 95 | -34 | -80 | 64 | -5.0 | -17 | 24 | 85 | -202 | -135 | |
| 0.9 | 1.1 | 1.5 | 2.0 | 3.3 | 4.3 | 5.8 | 7.5 | 8.8 | 11 | 12 | 11 | |
| 1.9 | 4.9 | 7.8 | 14 | 21 | 32 | 32 | 37 | 49 | 54 | 53 | 43 | |
| 2.4 | 5.2 | 8.3 | 14 | 21 | 32 | 5.3 | 39 | 22 | – | – | – | |
| -8.2 | 37 | 59 | -3.8 | -33 | 5.4 | 48 | -103 | 49 | 166 | -40 | 47 | |
| 2.3 | 3.7 | 3.0 | 7.3 | 9.1 | 11 | 14 | 16 | 43 | 21 | 6.1 | 3.2 | |
| -2.3 | -185 | -214 | 32 | -165 | -51 | 100 | -46 | -120 | – | -7.9 | 140 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.3 | 0.6 | 0.5 | 3.7 | 0.9 | 1.4 | 1.4 | 1.8 | 2.1 | 2.0 | 2.0 | 1.3 | |
| 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.3 | 116 | 121 | 3.7 | 254 | 11 | 18 | 43 | 5.7 | 26 | 197 | 8.2 | |
| -23 | -42 | 1.9 | 2.0 | 9.7 | 24 | 113 | -20 | -90 | 0.2 | -13 | 13 | |
| -24 | 23 | 92 | -41 | -89 | 53 | -19 | -33 | -19 | 64 | -208 | -138 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.